the use of alzheimer’s disease plasma biomarkers in the clinic: further research needed
Published 2 years ago • 38 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
4:07
plasma versus neuroimaging biomarkers for alzheimer’s disease clinical trials
-
2:55
research priorities to achieve widespread use of blood-based biomarkers in alzheimer’s disease
-
1:45
the accuracy of plasma biomarkers for alzheimer’s disease outside of a controlled setting
-
2:57
the potential of plasma biomarkers in dementia
-
6:32
blood biomarkers in alzheimer’s disease: appropriate use recommendations
-
1:23
plasma biomarkers for alzheimer's disease as pre-screening tools
-
1:33
which plasma biomarkers hold the most promise in alzheimer’s disease?
-
1:46
challenges in the clinical implementation of alzheimer’s disease biomarkers
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
0:56
blood-based biomarkers for treatment monitoring in alzheimer’s disease
-
2:25
plasma biomarkers for population-based alzheimer’s disease screening
-
1:28
impact of blood-based biomarkers on alzheimer’s disease treatments
-
58:02
what advances in blood biomarker research could mean for the future of alzheimer's disease
-
3:28
diagnostic biomarkers on the horizon in alzheimer’s disease
-
1:40
blood-based biomarkers for alzheimer’s disease screening
-
3:17
blood biomarkers for the differential diagnosis of alzheimer’s disease in clinical practice
-
4:34
a future scenario: digital and blood biomarkers for alzheimer’s disease diagnosis in primary care
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap